Llucia Prohens
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls" [European Neuropsychopharmacology 81 (2024) 28-37].
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: April 13, 2026
Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: November 25, 2024
Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophrenia.
Journal: Translational psychiatry
Published: April 29, 2024
Polygenic risk scores mediating functioning outcomes through cognitive and clinical features in youth at family risk and controls.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: November 03, 2023
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk.
Journal: Psychiatry research
Published: October 23, 2023
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophrenia.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 09, 2023
The polygenic basis of relapse after a first episode of schizophrenia.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: February 15, 2023
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort.
Journal: Psychiatry research
Published: February 06, 2023
Early treatment with JNJ-46356479, a mGluR2 modulator, improves behavioral and neuropathological deficits in a postnatal ketamine mouse model of schizophrenia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 27, 2022
Epigenetic clocks in relapse after a first episode of schizophrenia.
Journal: Schizophrenia (Heidelberg, Germany)
Published: May 05, 2022
Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data.
Journal: Frontiers in pharmacology
Published: June 23, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026